Fisher & Paykel Healthcare 관리
관리 기준 확인 3/4
Fisher & Paykel Healthcare CEO는 Lewis Gradon, Apr2016 에 임명되었습니다 의 임기는 8.58 년입니다. 총 연간 보상은 NZ$ 3.53M, 50.6% 로 구성됩니다. 50.6% 급여 및 49.4% 보너스(회사 주식 및 옵션 포함). 는 NZ$ 21.81M 가치에 해당하는 회사 주식의 0.098% 직접 소유합니다. 21.81M. 경영진과 이사회의 평균 재임 기간은 각각 3.5 년과 4.5 년입니다.
주요 정보
Lewis Gradon
최고 경영자
NZ$3.5m
총 보상
| CEO 급여 비율 | 50.6% |
| CEO 임기 | 8.6yrs |
| CEO 소유권 | 0.1% |
| 경영진 평균 재임 기간 | 3.5yrs |
| 이사회 평균 재임 기간 | 4.5yrs |
최근 관리 업데이트
Recent updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | NZ$4m | NZ$2m | NZ$133m |
| Dec 31 2023 | n/a | n/a | NZ$197m |
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$3m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
보상 대 시장: Lewis 의 총 보상 ($USD 2.10M ) NZ 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 4.41M ).
보상과 수익: Lewis 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.
CEO
Lewis Gradon (63 yo)
8.6yrs
테뉴어
NZ$3,533,971
보상
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Chief Financial Officer | 5.7yrs | 데이터 없음 | 0.0045% NZ$ 1.0m | |
| COO & GM of Respiratory Humidification | less than a year | 데이터 없음 | 0.00060% NZ$ 133.6k | |
| Vice President of Products & Technology | 8.6yrs | 데이터 없음 | 0.019% NZ$ 4.2m | |
| Head of Capital Markets & Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Company Secretary & General Counsel | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Communications & Investor Relations Manager | no data | 데이터 없음 | 데이터 없음 | |
| VP of Sales & Marketing and President of North America & Europe | less than a year | 데이터 없음 | 0.029% NZ$ 6.4m | |
| Vice President of Human Resources | 4.1yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Supply Chain | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Corporate | no data | 데이터 없음 | 데이터 없음 | |
| General Manager of Airvo Optiflow | no data | 데이터 없음 | 데이터 없음 |
3.5yrs
평균 재임 기간
경험이 풍부한 관리: FPH 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Non-Executive Director | 23yrs | NZ$188.15k | 0.15% NZ$ 34.2m | |
| Independent Chairman of the Board | 6yrs | NZ$220.74k | 0.0013% NZ$ 282.8k | |
| Independent Non-Executive Director | 3.1yrs | NZ$212.77k | 0.0023% NZ$ 514.4k | |
| Member of EcoDesign Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Non-Executive Independent Director | 1.1yrs | NZ$93.48k | 0.00032% NZ$ 71.3k | |
| Independent Non-Executive Director | 7.4yrs | NZ$179.08k | 0.00065% NZ$ 144.7k | |
| Independent Non-Executive Director | 2.4yrs | NZ$160.13k | 0.00033% NZ$ 73.5k | |
| Member of EcoDesign Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of EcoDesign Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of EcoDesign Advisory Board | no data | 데이터 없음 | 데이터 없음 |
4.5yrs
평균 재임 기간
63yo
평균 연령
경험이 풍부한 이사회: FPH 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.